INVESTEC PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.1 EUR | +0.71% |
|
+3.65% | +16.28% |
| Jul. 01 | New semester, new state of mind |  |
| Jul. 01 | Berenberg raises Centrica; UBS likes Rentokil | AN |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Its low valuation, with P/E ratio at 197.34 and 182.48 for the ongoing fiscal year and 2026 respectively, makes the stock pretty attractive with regard to earnings multiples.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Diversified Investment Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +16.28% | 6.54B | - | - | |
| +10.77% | 50.27B | B- | ||
| +27.30% | 13.79B | B+ | ||
| -1.49% | 7.24B | B+ | ||
| -14.63% | 2.88B | B+ | ||
| +26.04% | 2.11B | C+ | ||
| +20.97% | 1.98B | C | ||
| +6.42% | 1.33B | - | - | |
| -2.68% | 1.28B | - | B+ | |
| -12.80% | 1.2B | - |
Investor Rating
-
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- INL Stock
- IVKA Stock
- Ratings Investec plc
